In recent market activity, Arcosa Inc (Symbol: ACA) has seen its stock price climb above the average analyst 12-month target of $105.20, currently trading at $105.72 per share. This upward movement prompts a critical question for analysts: should they downgrade the stock based on its new valuation or increase their target price? The decision often hinges on the company’s recent performance and potential for future growth.
Currently, the average price target is derived from five analyst estimates within the Zacks coverage universe. While the average price target stands at $105.20, individual analyst targets vary, with some suggesting a lower price of $95.00 and one predicting a peak of $110.00. The standard deviation among these targets is $6.14, indicating a range of opinions on Arcosa’s value.
The significance of the average target lies in its ability to incorporate the “wisdom of the crowd.” By aggregating various analyst viewpoints, investors gain insight beyond a single expert’s opinion. As ACA trades above the $105.20 mark, shareholders are prompted to evaluate whether this represents a checkpoint on the way to a higher price point or if it signals that the stock is overvalued. Below is an overview of the current analyst ratings for Arcosa Inc:
Recent ACA Analyst Ratings Breakdown | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
Strong buy ratings: | 5 | 4 | 4 | 5 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
The average rating noted in the table ranges from 1 to 5, where 1 represents a Strong Buy and 5 signifies a Strong Sell. This analysis utilized data from Zacks Investment Research via Quandl.com. For further insights, you can access the latest Zacks research report on ACA — FREE.
10 ETFs With Most Upside To Analyst Targets »
Also see:
– Technology Stocks Hedge Funds Are Selling
– Bunge Global SA Average Annual Return
– NUW Historical Stock Prices
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.